Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19
Juan G. Ripoll, Ellen K. Gorman, Justin E. Juskewitch, et al.
Blood Advances (2022) Vol. 6, Iss. 23, pp. 5951-5955
Open Access | Times Cited: 24

Showing 24 citing articles:

Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
Evan M. Bloch, Daniele Focosi, Shmuel Shoham, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. 11, pp. 2018-2024
Open Access | Times Cited: 37
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
Akshita Gupta, Angelina Konnova, Mathias Smet, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 30
Mortality Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2023) Vol. 7, Iss. 5, pp. 499-513
Open Access | Times Cited: 28
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19
Juan G. Ripoll, Sidna M. Tulledge‐Scheitel, Anthony A. Stephenson, et al.
mBio (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 6
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial
Simone Hoffmann, Eva Schrezenmeier, Maxime Desmarets, et al.
EBioMedicine (2025) Vol. 113, pp. 105613-105613
Open Access
Treatment of chronic COVID‐19 with convalescent/postvaccination plasma in patients with hematologic malignancies
Maike Janssen, Albrecht Leo, Cornelia Wolf, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 4, pp. 618-626
Open Access | Times Cited: 3
Charting a path forward: Promising outcomes of convalescent plasma therapy in the care of severely B‐cell depleted patients with persistent COVID‐19
Tsofia Inbar, Eldad J. Dann, Omer Kerner, et al.
Transfusion (2024) Vol. 64, Iss. 3, pp. 443-448
Closed Access | Times Cited: 2
Convalescent Plasma and the US Expanded Access Program: A Personal Narrative
Michael J. Joyner
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 2
Generating the Evidence Base for Convalescent Plasma Use for a New Infectious Disease
Hyunah Yoon, Liise‐anne Pirofski
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 2
Mortality rates among hospitalized patients with COVID-19 treated with convalescent plasma A Systematic review and meta-analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes
Wenjing Guo, Yizhou Zheng, Sizhou Feng
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 7
The value of observational registry studies for the next infectious disease emergency
Jonathon W. Senefeld, Peter Marks, Arturo Casadevall, et al.
mBio (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 5
Convalescent Plasma for Immunocompromised Patients
Shmuel Shoham
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism
Pei Ye Li, Philip S. Yu, Allen Li, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 2, pp. 100068-100068
Open Access | Times Cited: 4
COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients
Mary J. Kasten, Brian D. Lahr, Anusha Parisapogu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Neutralizing anti-spike monoclonal antibodies for COVID-19 in vulnerable populations: lessons learned and future directions
Raymund R. Razonable
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 7, pp. 619-631
Closed Access | Times Cited: 2
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Replacement Therapy for Immunocompromised Patients
Jonathon W. Senefeld, Michael J. Joyner
Clinical Infectious Diseases (2023) Vol. 77, Iss. 7, pp. 961-963
Closed Access | Times Cited: 2
COVID-19 convalescent plasma therapy through the lens of the third year of the pandemic
Liise-anne Pirofski
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 2, pp. 130-132
Open Access | Times Cited: 2
Reply to ‘Use of convalescent plasma in the treatment of COVID-19’
Naoka Murakami, Robert Hayden, Thomas Hills, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 4, pp. 272-272
Open Access
Towards a 21st century renaissance for passive immunity?
Michael J. Joyner
EBioMedicine (2023) Vol. 92, pp. 104626-104626
Open Access
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19
Juan G. Ripoll, Sidna M. Tulledge‐Scheitel, Anthony A. Stephenson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Commentary on “Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study”
Michael J. Joyner, Nigel Paneth
mBio (2022) Vol. 13, Iss. 6
Open Access
Page 1

Scroll to top